A novel combined systemic inflammation-based score can predict survival of intermediate-to-advanced hepatocellular carcinoma patients undergoing transarterial chemoembolization

Liu, Chang; Li, Lei; Lu, Wu-sheng; Du, Hua; Yan, Lu-nan; Wen, Tian-fu; Wei, Wu-ran; Jiang, Li; Xu, Ming-qing

doi:10.1186/s12885-018-4121-3

BMC Cancer

Article metrics
Last updated: Thu, 25 Apr 2024 11:31:48 Z

A novel combined systemic inflammation-based score can predict survival of intermediate-to-advanced hepatocellular carcinoma patients undergoing transarterial chemoembolization

Access & Citations

1692

Article Accesses
18

Web of Science
15

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com